Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5696398 | 0.79 | GRIK1 (0.36) | TSHRALDH1A1GRIK1GRIK2 | |
| SCHEMBL16553409 | 0.76 | ALDH1A1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL27820986 | 0.73 | ALDH1A1 (0.34) | TSHRALDH1A1 | |
| SCHEMBL2939728 | 0.71 | TSHR (0.37) | TSHRALDH1A1 | |
| SCHEMBL28357452 | 0.71 | ALDH1A1 (0.35) | TSHRALDH1A1 | |
| SCHEMBL3675285 | 0.71 | ALDH1A1 (0.38) | TSHRALDH1A1 | |
| SCHEMBL3195147 | 0.70 | ALDH1A1 (0.34) | TSHRALDH1A1 | |
| SCHEMBL4415293 | 0.69 | TSHR (0.35) | TSHRALDH1A1 | |
| SCHEMBL2143318 | 0.68 | ALDH1A1 (0.35) | TSHRALDH1A1 | |
| SCHEMBL2641113 | 0.68 | ALDH1A1 (0.35) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116867885-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-115297822-A | Consumer product comprising a plurality of microcapsules defined by an average total surface area | 奇华顿股份有限公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-1663139-A1 | CONDITIONING COMPOSITION COMPRISING CATIONIC CROSSLINKED THICKENING POLYMER AND NONIONIC SURFACTANT | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20050002892-A1 | Conditioning composition comprising cationic crosslinked thickening polymer and nonionic surfactant | THE PROCTER & GAMBLE COMPANY | 2005-01-06 | — | — | US | disclosed |
| WO-2004108101-A1 | CONDITIONING COMPOSITION COMPRISING CATIONIC CROSSLINKED THICKENING POLYMER AND NONIONIC SURFACTANT | THE PROCTER & GAMBLE COMPANY (US) | 2004-12-16 | — | — | WO | disclosed |
| WO-2004035016-A1 | CONDITIONING COMPOSITION COMPRISING CATIONIC CROSSLINKED POLYMER | THE PROCTER & GAMBLE COMPANY (US) | 2004-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050002892-A1 | Conditioning composition comprising cationic crosslinked thickening polymer and nonionic surfactant | CUTA, PCNA, DSG1 | TSHR 4428/4885ALDH1A1 3715/4885GRIK1 924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.